Bon Natural Life Ltd (BON): Price and Financial Metrics
BON Price/Volume Stats
|Current price||$0.70||52-week high||$5.34|
|Prev. close||$0.74||52-week low||$0.52|
|Day high||$0.74||Avg. volume||200,119|
|50-day MA||$1.01||Dividend yield||N/A|
|200-day MA||$1.43||Market Cap||5.89M|
BON Stock Price Chart Interactive Chart >
BON Stock Summary
- BON has a higher market value than only 1.95% of US stocks; more precisely, its current market capitalization is $5,457,547.
- BON's went public 1.92 years ago, making it older than merely 5.5% of listed US stocks we're tracking.
- With a price/earnings ratio of 0.87, BON NATURAL LIFE LTD P/E ratio is greater than that of about just 0.99% of stocks in our set with positive earnings.
- Stocks that are quantitatively similar to BON, based on their financial statements, market capitalization, and price volatility, are ZEV, MYGN, XGN, ITI, and DUOT.
- To dig deeper into the stock's financial statements, go to BON's page on browse-edgar?action=getcompany&CIK=0001816815.
BON Valuation Summary
- BON's EV/EBIT ratio is 1.2; this is 93.6% lower than that of the median Consumer Defensive stock.
- BON's EV/EBIT ratio has moved down 14.6 over the prior 23 months.
Below are key valuation metrics over time for BON.
Bon Natural Life Ltd (BON) Company Bio
Bon Natural Life Limited engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company sells its products to customers in Chinese and international markets. Bon Natural Life Limited was founded in 2006 and is headquartered in Cayman Islands.
Most Popular Stories View All
BON Latest News Stream
|Loading, please wait...|
BON Latest Social Stream
View Full BON Social Stream
Latest BON News From Around the Web
Below are the latest news stories about BON NATURAL LIFE LTD that investors may wish to consider to help them evaluate BON as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning!
Bon Natural Life Limited Appoints Wallace Lee as New Chief Financial Officer
XIAN, China, April 25, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, is pleased to announce the appointment of Mr. Wallace Lee as Chief Financial Officer (CFO), effective April 17, 2023. Mr. Lee succeeds Zhenchao Li, who stepped down from the role of CFO after a 4-year career with the Company, effective April 17, 2023. “We welcome Wallace Lee into
Bon Natural Life Limited Announces Record-Setting Full Fiscal Year 2022 Results
Revenue increased by 17.3% to $29.9 million.Delivered full fiscal year 2022 net income of $6.2 million, or $0.74 per diluted share. Xian, China, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its 2022 annual financial results for the fiscal year ended September 30, 2022. FY 2022 Financial Highlights Total net revenues were
Bon Natural Life Limited Announces FY2022 Earnings Release Date and Webcast
Earnings to be released before market opens on Friday, February 10, 2023 XIAN, China, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its FY2022 earnings release for the fiscal year ended September 30, 2021 before the market open on Friday, February 10, 2023. BON will also host an investor conference call and webcast on the same
Bon Natural Life Limited Provides Update on Its Expansion Project
Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that there will be a delay to the initial production target of Q4 2022 for its third production site – Yumen Plant to May 2023.
BON Price Returns
Loading social stream, please wait...